Fenimore Asset Management Inc Merck & Co., Inc. Transaction History

Fenimore Asset Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	BUY	$102.95 - $114.33 $725,797 - $806,026	7,050 New	7,050 $725,000
Q1 2023 Apr 20, 2023	BUY	$102.94 - $114.86 $726,756 - $810,911	7,060 New	7,060 $751,000
Q2 2022 Jul 26, 2022	BUY	$83.49 - $94.64 $5,844 - $6,624	70 Added 0.93%	7,605 $693,000
Q4 2021 Jan 13, 2022	SELL	$72.28 - $90.54 $8,167 - $10,231	-113 Reduced 1.48%	7,535 $577,000
Q3 2021 Oct 26, 2021	SELL	$71.68 - $78.83 $13,404 - $14,741	-187 Reduced 2.39%	7,648 $574,000
Q1 2021 Apr 16, 2021	SELL	$68.86 - $81.11 $6,886 - $8,111	-100 Reduced 1.26%	7,835 $604,000
Q1 2020 Apr 24, 2020	BUY	$63.36 - $87.82 $37,382 - $51,813	590 Added 8.03%	7,935 $611,000
Q2 2019 Jul 16, 2019	SELL	$69.84 - $81.59 $509,133 - $594,791	-7,290 Closed	0 $0
Q4 2018 Jan 11, 2019	SELL	$65.24 - $75.71 $9,329 - $10,826	-143 Reduced 1.92%	7,290 $557,000
Q2 2018 Jul 11, 2018	SELL	$50.83 - $59.72 $1,372 - $1,612	-27 Reduced 0.36%	7,433 $451,000
Q4 2017 Feb 06, 2018	SELL	$51.62 - $61.64 $16,673 - $19,909	-323 Reduced 4.15%	7,460 $420,000
Q3 2017 Oct 17, 2017	BUY	$58.67 - $63.13 $456,628 - $491,340	7,783	7,783 $498,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Fenimore Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Fenimore Asset Management Inc with notifications on news.